Concepedia

Aprepitant in combination with palonosetron for the prevention of postoperative nausea and vomiting in female patients using intravenous patient-controlled analgesia

Jae Hwa Yoo, Soon Im Kim, Ji Won Chung, Mi Roung Jun, Yoo Mi Han, Yong Jik Kim

Korean journal of anesthesiology · 2018 · 26 citations · 22 references

DOIFull text

Open access

Abstract

Aprepitant combined with palonosetron did not reduce the incidence of PONV as compared to palonosetron alone within 24 h of surgery in women receiving fentanyl-based IV-PCA.

References

22

A Simplified Risk Score for Predicting Postoperative Nausea and Vomiting 

Christian C. Apfel, Esa Läärä, M. Koivuranta et al. · Anesthesiology · 1999 · 2K citations · Full text

A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting

Christian C. Apfel, K. Korttila, Mona Abdalla et al. · New England Journal of Medicine · 2004 · 1.5K citations · Full text

Consensus Guidelines for the Management of Postoperative Nausea and Vomiting

Tong J. Gan, Pierre Diemunsch, Ashraf S. Habib et al. · Anesthesia & Analgesia · 2013 · 1.4K citations

, , +13

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Paul J. Hesketh, Steven M. Grunberg, Richard J. Gralla et al. · Journal of Clinical Oncology · 2003 · 770 citations

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

Richard J. Gralla, M. Lichinitser, S. van der Vegt et al. · Annals of Oncology · 2003 · 471 citations

, , +5